Revenue
14.3 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 14285000 USD Source
Annual consolidated revenue for 2025: about USD 53.43M, using the latest reported figures. The previous period, 2024, was about USD 25.38M.
14.3 million USD
2026 Q2 · USD
-320.76%
2026 Q2 · %
-43 million USD
2026 Q2 · USD
-43.5 million USD
2026 Q2 · USD
160080000 USD
294755090 shares
145.34% · 175 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
58.4 million USD
2025-07-01 – 2026-06-30
-107 million USD
2025-07-01 – 2026-06-30
-108 million USD
2025-07-01 – 2026-06-30
1.24 million USD
2025-07-01 – 2026-06-30
-110 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-13.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 25.38 million
–
Current period
USD 53.43 million
–
53426000 − 25384000 = 28042000 USD
25384000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source53426000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 169.93 million
–
Current period
−USD 52.49 million
–
-52489000 − -169925000 = 117436000 USD
-169925000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-52489000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 170.49 million
–
Current period
−USD 58.14 million
–
-58135000 − -170491000 = 112356000 USD
-170491000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-58135000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 140,000
–
Current period
USD 155,000
–
155000 − 140000 = 15000 USD
140000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source155000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 0 | 212758000 Derived | -212758000 | -14115000 Derived | -198643000 | -173779000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 25384000 | 202260000 Derived | -176876000 | -6951000 Derived | -169925000 | -170631000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 53426000 | 108986000 Derived | -55560000 | -3071000 Derived | -52489000 | -58290000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 0 |
|
| 2024 | Revenue | 25384000 |
|
| 2025 | Revenue | 53426000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | No prior comparable period |
|
| 2025 | Year over year | 110.5% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | Not reported |
|
| 2024 | Operating margin | -696.8% |
|
| 2025 | Operating margin | -104% |
|
| 2023 | Net margin | Not reported |
|
| 2024 | Net margin | -669.4% |
|
| 2025 | Net margin | -98.2% |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | -672.2% |
|
| 2025 | Free cash flow margin | -109.1% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -173164000 |
|
| 2024 | Operating cash flow | -170491000 |
|
| 2025 | Operating cash flow | -58135000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -173779000 |
|
| 2024 | Free cash flow | -170631000 |
|
| 2025 | Free cash flow | -58290000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Liabilities / assets | 22.6% |
|
| 2024 | Liabilities / assets | 47.9% |
|
| 2025 | Liabilities / assets | 12.8% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Current assets / current liabilities | 4.47× |
|
| 2024 | Current assets / current liabilities | 1.62× |
|
| 2025 | Current assets / current liabilities | 7.24× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2020-04-01 – 2021-03-31 | −USD 38.7 million Exact valueExact value: -38700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2021 2020-07-01 – 2021-06-30 | −USD 83.37 million Exact valueExact value: -83373000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2021 2020-10-01 – 2021-09-30 | −USD 143.75 million Exact valueExact value: -143748000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 226.79 million Exact valueExact value: -226790000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 184.74 million Exact valueExact value: -184736000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 84,000 Exact valueExact value: 84000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 184.82 million Calculation and evidence-184736000 − 84000 USD Exact free cash flow: -184820000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 241.32 million Exact valueExact value: -241317000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 219.99 million Exact valueExact value: -219987000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.71 million Exact valueExact value: 1705000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 221.69 million Calculation and evidence-219987000 − 1705000 USD Exact free cash flow: -221692000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 198.64 million Exact valueExact value: -198643000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 173.16 million Exact valueExact value: -173164000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 615,000 Exact valueExact value: 615000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 173.78 million Calculation and evidence-173164000 − 615000 USD Exact free cash flow: -173779000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 169.93 million Exact valueExact value: -169925000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 170.49 million Exact valueExact value: -170491000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 140,000 Exact valueExact value: 140000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 170.63 million Calculation and evidence-170491000 − 140000 USD Exact free cash flow: -170631000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 52.49 million Exact valueExact value: -52489000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 58.14 million Exact valueExact value: -58135000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 155,000 Exact valueExact value: 155000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 58.29 million Calculation and evidence-58135000 − 155000 USD Exact free cash flow: -58290000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
28 filings · 1,471 latest values · 1,471 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001832038, 1832038, ADGI, IVVD, edgar:1832038
Also known as Adagio Therapeutics, Inc., INVIVYD, INC., Invivyd, Inc.